AI-generated summary
The authors studied photobiomodulation (PBM) in a mouse model of spinal cord injury and in a macrophage-astrocyte co-culture. They report that PBM reduced GFAP expression, CSPG secretion and M1 macrophage numbers, and that it dampened astrocyte activation by regulating M1 macrophages, which they associate with less glial scar formation. The abstract does not report sample sizes or the light parameters used.
- Who or what was studied
- BALB/c mice with standardized bilateral spinal cord compression, and an in vitro macrophage-astrocyte co-culture model
- Limits stated in the abstract
- The findings come from an animal model and an in vitro co-culture, and the abstract does not state sample sizes or light parameters.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.